文献速递腹部CT

腹膜假黏液瘤:CT上的脏器扇贝样压迹是完全肿瘤细胞减灭术后的复发预测因素

Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery.
PubMed 文献 · Eur Radiol · 2020-03-24

本研究纳入64例接受完全肿瘤细胞减灭术(CC-0或CC-1)的初治腹膜假黏液瘤患者,分析术前增强CT上肝脏扇贝样压迹与无病生存期(DFS)的关系。中位随访24.3个月,40/64例(63.4%)存在肝脏扇贝样压迹,其DFS显著短于无压迹者(p=0.001;风险比4.3)。多因素Cox回归显示肝脏扇贝样压迹是DFS的独立预测因素(p=0.031);有压迹者中黏液沉积厚度≥20 mm与更差DFS显著相关(p=0.042)。

要点

  • 肝脏扇贝样压迹是腹膜假黏液瘤患者完全肿瘤细胞减灭术后的独立复发预测因素(p=0.031)。
  • 有肝脏扇贝样压迹者DFS显著短于无压迹者(p=0.001;风险比4.3)。
  • 有压迹者中肝表面黏液沉积厚度≥20 mm与更差DFS显著相关(p=0.042)。

核心结论

  • 肝脏扇贝样压迹是独立于组织学分级和肿瘤标志物的预后因素,其存在可导致完全肿瘤细胞减灭术后高复发率。

研究设计与样本

  • 回顾性分析2012年9月至2018年12月间159例连续腹膜假黏液瘤患者中64例初治、随后接受完全肿瘤细胞减灭术(CC-0或CC-1)者。
  • 术前增强CT评估肝脏扇贝样压迹及肝表面黏液沉积最大厚度,DFS由术后CT特征联合肿瘤标志物确定。

关键影像表现/征象

  • CT显示64例中40例(63.4%)存在肝脏扇贝样压迹。
  • 有扇贝样压迹者中,肝表面黏液沉积厚度≥20 mm与更差DFS显著相关(p=0.042)。

诊断标准与关键数值

  • 肝脏扇贝样压迹:CT上肝脏表面受压呈扇贝样改变,64例中40例(63.4%)存在。
  • 黏液沉积厚度阈值:肝表面黏液沉积最大厚度≥20 mm。
  • DFS:基于术后CT特征与肿瘤标志物联合判定。

临床应用与阅片要点

  • 术前增强CT评估肝脏扇贝样压迹及其黏液沉积厚度,有助于识别完全肿瘤细胞减灭术后高复发风险患者。
  • 肝脏扇贝样压迹的存在及黏液沉积厚度≥20 mm可作为术后随访策略制定的参考因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Pseudomyxoma peritonei (PMP) is characterized by peritoneal dissemination of gelatinous ascites following rupture of a mucinous tumor. Treatment by cytoreductive surgery (CRS) has improved its prognosis. Although visceral scalloping, notably liver scalloping, on computed tomography (CT) is a typical feature of PMP, its prognostic value remains unknown. We aimed to investigate the efficacy of liver scalloping in predicting recurrence in PMP patients.

METHODS: Among 159 consecutive patients with PMP who had contrast-enhanced CT between September 2012 and December 2018, 64 treatment-naïve patients who subsequently underwent CRS with complete resection (i.e., completeness of cytoreduction score (CC)-0 or CC-1), were included in analysis. Presence of liver scalloping and maximum thickness of mucin deposition at the liver surface were evaluated on CT. Disease-free survival (DFS) was determined based on the combination of postoperative CT features and tumor marker values.

RESULTS: Median follow-up was 24.3 months. CT revealed liver scalloping in 40/64 (63.4%) patients. Kaplan-Meier analysis showed significantly shorter DFS in patients with scalloping than in those without (p = 0.001; hazard ratio, 4.3). In patients with scalloping, greater mucin deposition (thickness ≥ 20 mm) significantly correlated with poorer DFS (p = 0.042). In multivariate Cox proportional hazards regression including CC status, pathologic type, and tumor markers, the presence of scalloping independently and significantly correlated with DFS (p = 0.031).

CONCLUSIONS: Liver scalloping was an independent predictor even after adjusting for clinical covariates. The presence of liver scalloping can lead to a high recurrence rate after CRS.

KEY POINTS: • The presence of liver scalloping is a prognostic factor independent of histological grade and tumor markers. • Greater mucin deposition (thickness ≥ 20 mm at the liver surface) is associated with higher recurrence rates in patients with liver scalloping.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Hotta M, Minamimoto R, Gohda Y, et al. Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery. Eur Radiol. 2020. PMID: 32211961. doi:10.1007/s00330-020-06756-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。